X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (14) 14
male (14) 14
prostate cancer (11) 11
urology (10) 10
urology & nephrology (9) 9
magnetic resonance imaging (7) 7
oncology (7) 7
aged (6) 6
men (6) 6
prostatic neoplasms - diagnosis (6) 6
prostatic neoplasms - pathology (6) 6
middle aged (5) 5
risk factors (5) 5
surveillance (5) 5
abridged index medicus (4) 4
biopsy (4) 4
cancer (4) 4
neoplasm staging (4) 4
prostate-specific antigen - blood (4) 4
prostatic neoplasms (4) 4
prostatic neoplasms - therapy (4) 4
radical prostatectomy (4) 4
surgery (4) 4
treatment outcome (4) 4
active surveillance (3) 3
chemotherapy (3) 3
disease (3) 3
focal therapy (3) 3
health aspects (3) 3
management (3) 3
neoplasm grading (3) 3
patient selection (3) 3
prognosis (3) 3
program (3) 3
prostate (3) 3
prostatectomy - methods (3) 3
prostatic neoplasms - blood (3) 3
prostatic neoplasms - surgery (3) 3
risk assessment (3) 3
usage (3) 3
adult (2) 2
biomarkers (2) 2
biomarkers, tumor - blood (2) 2
carcinoma (2) 2
care and treatment (2) 2
clinical stage (2) 2
complications (2) 2
diagnosis (2) 2
disease progression (2) 2
endorectal coil (2) 2
kallikreins - blood (2) 2
magnetic resonance imaging - methods (2) 2
mortality (2) 2
mri (2) 2
nephrectomy (2) 2
orchiectomy - methods (2) 2
patients (2) 2
predictive value of tests (2) 2
prostate - pathology (2) 2
prostatectomy (2) 2
prostatic neoplasms - mortality (2) 2
radiation-therapy (2) 2
radiology, nuclear medicine & medical imaging (2) 2
radiotherapy (2) 2
research (2) 2
risk (2) 2
testicular cancer (2) 2
testicular neoplasms - therapy (2) 2
therapy (2) 2
time factors (2) 2
watchful waiting (2) 2
ablation (1) 1
active surveillance cohort (1) 1
adjuvant radiation (1) 1
adjuvant radiotherapy (1) 1
adjuvant sunitinib (1) 1
adverse pathological features (1) 1
aged, 80 and over (1) 1
analysis (1) 1
andrology (1) 1
animals (1) 1
antigen levels (1) 1
antigens (1) 1
antigens, neoplasm - blood (1) 1
antineoplastic agents - therapeutic use (1) 1
article (1) 1
article subject (1) 1
bacteriochlorophylls - therapeutic use (1) 1
biochemical failure (1) 1
biological markers (1) 1
biomarkers, tumor (1) 1
biomarkers, tumor - genetics (1) 1
biopsy schemes (1) 1
bladder cancer (1) 1
brachytherapy - methods (1) 1
brca2 mutation carriers (1) 1
breast (1) 1
c-11-acetate (1) 1
cancer data-base (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Urology, The, ISSN 0022-5347, 2017, Volume 198, Issue 5, pp. 1027 - 1032
Abstract Introduction Several case reports have documented rare spontaneous cancer regression following systemic infections. Immune-related targeted therapies... 
Urology | immune system | mortality | renal cell | infection | nephrectomy | carcinoma | POPULATION | OSTEOSARCOMA PATIENTS | RISK | POSTOPERATIVE INFECTION | SURVEILLANCE | UROLOGY & NEPHROLOGY | COMPLICATIONS | EPIDEMIOLOGY | PROGRAM | Health aspects | Confidential communications | Carcinoma, Renal cell
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2016
Abstract Purpose Following an initial negative biopsy, there is an ongoing need for strategies to improve patient selection for repeat biopsy as well as the... 
Urology
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 4, pp. 414 - 424
Purpose Guidelines are limited for genetic testing for prostate cancer (PCA). The goal of this conference was to develop an expert consensus-driven working... 
MISMATCH-REPAIR DEFICIENCY | BRCA2 MUTATION CARRIERS | ONCOLOGY | PD-1 BLOCKADE | DNA | MEN | GERMLINE MUTATIONS | HOXB13 G84E MUTATION | SUSCEPTIBILITY GENE | LYNCH SYNDROME | BREAST | Special
Journal Article
FUTURE ONCOLOGY, ISSN 1479-6694, 05/2019, Volume 15, Issue 15, pp. 1683 - 1695
Patients with high-risk renal cell carcinoma (RCC) experience high rates of recurrence despite definitive surgical resection. Recent trials of adjuvant... 
clinical trial | PLACEBO | MANAGEMENT | nivolumab | UPDATED EUROPEAN ASSOCIATION | PROSPER RCC | neoadjuvant therapy | ADJUVANT SUNITINIB | kidney cancer | TRIAL | perioperative | renal cell carcinoma | ONCOLOGY | HIGH-RISK | presurgical | UROLOGY GUIDELINES | nephrectomy
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2015, Volume 193, Issue 1, pp. 95 - 102
Purpose To our knowledge factors affecting the adoption of noncurative initial management in the United States for low risk prostate cancer on a population... 
Urology | prostate | risk | SEER program | trends | prostatic neoplasms | Risk | Prostatic neoplasms | Trends | Prostate | RADICAL PROSTATECTOMY | THERAPY | DATABASE | ACTIVE SURVEILLANCE | MEN | UROLOGY & NEPHROLOGY | UPDATE | DATA-BASE | CARCINOMA | PROGRAM | Risk Assessment | United States | Humans | Middle Aged | Male | Aged | Watchful Waiting - trends | Prostatic Neoplasms - therapy | Medical colleges | Prostate cancer | Health aspects | Risk factors
Journal Article
TheScientificWorldJournal, ISSN 1537-744X, 10/2008, Volume 8, pp. 963 - 973
Journal Article
Oncotarget, ISSN 1949-2553, 04/2018, Volume 9, Issue 30, pp. 21359 - 21365
There is a significant controversy on whether race should be a factor in considering active surveillance for low-risk prostate cancer. To address this... 
Prostate cancer | Racial disparity | Active surveillance
Journal Article
ONCOLOGY, ISSN 0890-9091, 2009, Volume 23, Issue 11, pp. 974 - 979
The management of localized prostate cancer in an otherwise healthy male is complex, evolving, and largely consists of three modalities: surgery, radiation,... 
PSA DOUBLING TIME | MANAGEMENT | THERAPY | ONCOLOGY | MEN | DISEASE | CANDIDATES | OUTCOMES | INTERVENTION | Prostatic Neoplasms - pathology | Humans | Risk Factors | Male | Clinical Trials as Topic | Prostatic Neoplasms - diagnosis | Biomarkers, Tumor | Sentinel Surveillance | Prostatic Neoplasms - epidemiology
Journal Article